{"nct_id":"NCT04624204","title":"Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2020-12-08","start_date_type":"ACTUAL","primary_completion_date":"2027-10-28","primary_completion_date_type":"ESTIMATED","completion_date":"2027-10-28","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}